Does Medical Therapy Improve SinoNasal Outcomes Test–22 Domain Scores? An Analysis of Clinically Important Differences

Naweed I. Chowdhury, Jess C. Mace, Todd E. Bodner, Jeremiah A. Alt, Adam S. Deconde, Joshua M. Levy, Timothy Smith

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Objectives/Hypothesis: Minimum clinically important differences (MCIDs) for the 22-item SinoNasal Outcomes Test (SNOT-22) in patients with chronic rhinosinusitis (CRS) electing endoscopic sinus surgery (ESS) are well described. However, similar estimations for the MCID have not been investigated for patients electing continued appropriate medical therapy (CAMT). We sought to determine MCID values for a medically treated CRS cohort and compare them to historical MCIDs associated with ESS. Study Design: Prospective observational cohort study. Methods: One hundred twenty patients with refractory CRS electing CAMT were prospectively enrolled from academic referral clinics into an observational cohort study. Baseline and posttreatment SNOT-22 survey responses were collected. Four distribution-based methods for calculating MCIDs (e.g., half-standard deviation, Cohen's d, standard error of measurement, and minimum detectable change) were used to identify a range of MCID values for SNOT-22 total and domain scores. Results: The average MCID value for SNOT-22 total scores was 8.0, whereas mean MCID values for rhinologic, extranasal rhinologic, ear/facial, psychological, and sleep symptom domain scores were 3.9, 2.5, 3.3, 3.4, and 2.9, respectively, comparable to previously reported values for patients electing ESS. Although change in SNOT-22 total scores following CAMT exceeded the MCID, none of the average SNOT-22 domain score improvements surpassed their respective MCID thresholds. Conclusions: MCID values for SNOT-22 total and domain scores in patients electing CAMT are similar to previously published MCID values associated with ESS, indicating that MCID values are independent of treatment modality selection. Therefore, despite evidence of statistical significance, CAMT for CRS may not be associated with clinically discernable improvements in average SNOT-22 domain scores. Level of Evidence: 2c Laryngoscope, 2018.

Original languageEnglish (US)
JournalLaryngoscope
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Observational Studies
Cohort Studies
Therapeutics
Laryngoscopes
Ear
Sleep
Referral and Consultation
Prospective Studies
Psychology
Surveys and Questionnaires

Keywords

  • chronic disease
  • paranasal sinuses
  • quality of life
  • Sinusitis

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Does Medical Therapy Improve SinoNasal Outcomes Test–22 Domain Scores? An Analysis of Clinically Important Differences. / Chowdhury, Naweed I.; Mace, Jess C.; Bodner, Todd E.; Alt, Jeremiah A.; Deconde, Adam S.; Levy, Joshua M.; Smith, Timothy.

In: Laryngoscope, 01.01.2018.

Research output: Contribution to journalArticle

Chowdhury, Naweed I. ; Mace, Jess C. ; Bodner, Todd E. ; Alt, Jeremiah A. ; Deconde, Adam S. ; Levy, Joshua M. ; Smith, Timothy. / Does Medical Therapy Improve SinoNasal Outcomes Test–22 Domain Scores? An Analysis of Clinically Important Differences. In: Laryngoscope. 2018.
@article{3cf516ce00cb426e89a314a3b99143fa,
title = "Does Medical Therapy Improve SinoNasal Outcomes Test–22 Domain Scores? An Analysis of Clinically Important Differences",
abstract = "Objectives/Hypothesis: Minimum clinically important differences (MCIDs) for the 22-item SinoNasal Outcomes Test (SNOT-22) in patients with chronic rhinosinusitis (CRS) electing endoscopic sinus surgery (ESS) are well described. However, similar estimations for the MCID have not been investigated for patients electing continued appropriate medical therapy (CAMT). We sought to determine MCID values for a medically treated CRS cohort and compare them to historical MCIDs associated with ESS. Study Design: Prospective observational cohort study. Methods: One hundred twenty patients with refractory CRS electing CAMT were prospectively enrolled from academic referral clinics into an observational cohort study. Baseline and posttreatment SNOT-22 survey responses were collected. Four distribution-based methods for calculating MCIDs (e.g., half-standard deviation, Cohen's d, standard error of measurement, and minimum detectable change) were used to identify a range of MCID values for SNOT-22 total and domain scores. Results: The average MCID value for SNOT-22 total scores was 8.0, whereas mean MCID values for rhinologic, extranasal rhinologic, ear/facial, psychological, and sleep symptom domain scores were 3.9, 2.5, 3.3, 3.4, and 2.9, respectively, comparable to previously reported values for patients electing ESS. Although change in SNOT-22 total scores following CAMT exceeded the MCID, none of the average SNOT-22 domain score improvements surpassed their respective MCID thresholds. Conclusions: MCID values for SNOT-22 total and domain scores in patients electing CAMT are similar to previously published MCID values associated with ESS, indicating that MCID values are independent of treatment modality selection. Therefore, despite evidence of statistical significance, CAMT for CRS may not be associated with clinically discernable improvements in average SNOT-22 domain scores. Level of Evidence: 2c Laryngoscope, 2018.",
keywords = "chronic disease, paranasal sinuses, quality of life, Sinusitis",
author = "Chowdhury, {Naweed I.} and Mace, {Jess C.} and Bodner, {Todd E.} and Alt, {Jeremiah A.} and Deconde, {Adam S.} and Levy, {Joshua M.} and Timothy Smith",
year = "2018",
month = "1",
day = "1",
doi = "10.1002/lary.27470",
language = "English (US)",
journal = "Laryngoscope",
issn = "0023-852X",
publisher = "John Wiley and Sons Inc.",

}

TY - JOUR

T1 - Does Medical Therapy Improve SinoNasal Outcomes Test–22 Domain Scores? An Analysis of Clinically Important Differences

AU - Chowdhury, Naweed I.

AU - Mace, Jess C.

AU - Bodner, Todd E.

AU - Alt, Jeremiah A.

AU - Deconde, Adam S.

AU - Levy, Joshua M.

AU - Smith, Timothy

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objectives/Hypothesis: Minimum clinically important differences (MCIDs) for the 22-item SinoNasal Outcomes Test (SNOT-22) in patients with chronic rhinosinusitis (CRS) electing endoscopic sinus surgery (ESS) are well described. However, similar estimations for the MCID have not been investigated for patients electing continued appropriate medical therapy (CAMT). We sought to determine MCID values for a medically treated CRS cohort and compare them to historical MCIDs associated with ESS. Study Design: Prospective observational cohort study. Methods: One hundred twenty patients with refractory CRS electing CAMT were prospectively enrolled from academic referral clinics into an observational cohort study. Baseline and posttreatment SNOT-22 survey responses were collected. Four distribution-based methods for calculating MCIDs (e.g., half-standard deviation, Cohen's d, standard error of measurement, and minimum detectable change) were used to identify a range of MCID values for SNOT-22 total and domain scores. Results: The average MCID value for SNOT-22 total scores was 8.0, whereas mean MCID values for rhinologic, extranasal rhinologic, ear/facial, psychological, and sleep symptom domain scores were 3.9, 2.5, 3.3, 3.4, and 2.9, respectively, comparable to previously reported values for patients electing ESS. Although change in SNOT-22 total scores following CAMT exceeded the MCID, none of the average SNOT-22 domain score improvements surpassed their respective MCID thresholds. Conclusions: MCID values for SNOT-22 total and domain scores in patients electing CAMT are similar to previously published MCID values associated with ESS, indicating that MCID values are independent of treatment modality selection. Therefore, despite evidence of statistical significance, CAMT for CRS may not be associated with clinically discernable improvements in average SNOT-22 domain scores. Level of Evidence: 2c Laryngoscope, 2018.

AB - Objectives/Hypothesis: Minimum clinically important differences (MCIDs) for the 22-item SinoNasal Outcomes Test (SNOT-22) in patients with chronic rhinosinusitis (CRS) electing endoscopic sinus surgery (ESS) are well described. However, similar estimations for the MCID have not been investigated for patients electing continued appropriate medical therapy (CAMT). We sought to determine MCID values for a medically treated CRS cohort and compare them to historical MCIDs associated with ESS. Study Design: Prospective observational cohort study. Methods: One hundred twenty patients with refractory CRS electing CAMT were prospectively enrolled from academic referral clinics into an observational cohort study. Baseline and posttreatment SNOT-22 survey responses were collected. Four distribution-based methods for calculating MCIDs (e.g., half-standard deviation, Cohen's d, standard error of measurement, and minimum detectable change) were used to identify a range of MCID values for SNOT-22 total and domain scores. Results: The average MCID value for SNOT-22 total scores was 8.0, whereas mean MCID values for rhinologic, extranasal rhinologic, ear/facial, psychological, and sleep symptom domain scores were 3.9, 2.5, 3.3, 3.4, and 2.9, respectively, comparable to previously reported values for patients electing ESS. Although change in SNOT-22 total scores following CAMT exceeded the MCID, none of the average SNOT-22 domain score improvements surpassed their respective MCID thresholds. Conclusions: MCID values for SNOT-22 total and domain scores in patients electing CAMT are similar to previously published MCID values associated with ESS, indicating that MCID values are independent of treatment modality selection. Therefore, despite evidence of statistical significance, CAMT for CRS may not be associated with clinically discernable improvements in average SNOT-22 domain scores. Level of Evidence: 2c Laryngoscope, 2018.

KW - chronic disease

KW - paranasal sinuses

KW - quality of life

KW - Sinusitis

UR - http://www.scopus.com/inward/record.url?scp=85053413877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053413877&partnerID=8YFLogxK

U2 - 10.1002/lary.27470

DO - 10.1002/lary.27470

M3 - Article

JO - Laryngoscope

JF - Laryngoscope

SN - 0023-852X

ER -